Metagenics, announced it has named Patrick Sly as CEO, effective immediately. A highly regarded executive in the health and wellness industry, Mr. Sly brings a wealth of relevant leadership experience to Metagenics. Current President and CEO Pat Smallcombe, who has led Metagenics through a period of tremendous growth …
Tyra Biosciences, Inc., a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced the appointment of two key members of its leadership team: Bhavesh Ashar as Chief Operating Officer and…
Cipla Limited announced that it has elevated Achin Gupta, Global Chief Operating Officer, Cipla Limited to MD & GCEO effective April 1, 2026, for a term of 5 years. The appointment will be proposed to the shareholders for their approval. Achin has been appointed as MD & GCEO Designate from January 1st, 2026. A…
AMR Clinical, a leading integrated research site organization, announced today that Dr. William B. Smith, founding CEO of the Company since its formal consolidation in 2017, will assume a new role as Founder and Vice Chairman of the Board of Directors effective December 1, 2025. Kari L. Delahunty, currently Chief Oper…
Southern California University of Health Sciences (SCU), a national leader in integrative Whole Health education, announced today that Provost Dr. Tamara Rozhon, EdD, has been appointed to the National Academies of Medicine's Global Forum on Innovation in Health Professional Education. The appointment places SCU among…
The American College of Medical Genetics and Genomics (ACMG) announced that Melanie Wells, MPH, CAE, Chief Executive Officer of ACMG and the ACMG Foundation for Genetic and Genomic Medicine (ACMGF), will step down from her role, concluding her tenure on November 21, 2025. Wells will continue to support the organizatio…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Mary Blenn has been appointed to the newly created role of Executive Vice President and Chief Operating Officer, effective immediately. Ms. Blenn wi…
Miami Biotech Collective ("MBC"), South Florida's largest and most influential community of biotech leaders, introduced its Board of Advisors and Women's Leadership Council, created to help advance the region's biotech future and build relationships, amplify influence and drive professional, company and regional growt…
BioCina, a leading pharmaceutical contract development and manufacturing organization (CDMO), announced that Dr. Thomas Broudy has been appointed as Chief Executive Officer to lead the company's growth of its biologic drug substance and sterile drug product development and manufacturing services. "BioCina is entering…
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced key additions to its executive leadership team. These appointments reflect the company's continued momentum and its commitment to scaling innovation, operational excellence, and strategic growth. The boa…
Page 7 of 14